Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules

AUTOR(ES)

Nelson, Christopher A.

FONTE

The National Academy of Sciences of the USA

RESUMO

Major histocompatibility complex (MHC) class II molecules bind antigenic peptides for display to T lymphocytes. Although the enzymes involved remain to be identified, it is commonly believed that class II associated peptides are released from intact antigens through a series of proteolytic steps carried out inside antigen presenting cells. We have examined the effect of amino acid substitutions on proteolytic processing of the model antigen hen-egg lysozyme (HEL). Altered HEL molecules, engineered by site-directed mutagenesis of a HEL cDNA, were expressed as separate stable transfectants in a B cell lymphoma line. Each transfectant processed a different mutant HEL protein for presentation on MHC class II. We purified the resulting class II-associated peptides and analyzed them by mass spectrometry. Our results strongly support the hypothesis that antigen processing continues after peptide binding to the MHC class II molecule and are most consistent with a scenario in which long peptides first bind to MHC class II and are then trimmed by exopeptidase.

Documentos Relacionados

• Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.
• Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides
• Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
• High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.
• Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.